$AKYA
Akoya Biosciences, Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024010883 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $18.81M $23.16M
YoY Change -25.39% -1.52%
Cost Of Revenue $7.090M $9.778M
YoY Change -28.66% -14.27%
Gross Profit $11.72M $13.39M
YoY Change -23.25% 10.48%
Gross Profit Margin 62.32% 57.79%
Selling, General & Admin $14.67M $19.09M
YoY Change -22.85% -15.92%
% of Gross Profit 125.15% 142.64%
Research & Development $4.474M $5.288M
YoY Change -13.51% -15.7%
% of Gross Profit 38.16% 39.5%
Depreciation & Amortization $1.825M $1.926M
YoY Change -28.99% 4.28%
% of Gross Profit 15.57% 14.39%
Operating Expenses $20.07M $24.47M
YoY Change -25.18% -21.97%
Operating Profit -$8.349M -$11.08M
YoY Change -27.72% -42.4%
Interest Expense -$2.625M -$2.606M
YoY Change 17.24% 19.82%
% of Operating Profit
Other Income/Expense, Net -$36.00K -$80.00K
YoY Change -80.54% -23.81%
Pretax Income -$10.49M -$13.10M
YoY Change -18.7% -36.96%
Income Tax $44.00K $47.00K
% Of Pretax Income
Net Earnings -$10.53M -$13.15M
YoY Change -18.45% -36.79%
Net Earnings / Revenue -55.98% -56.76%
Basic Earnings Per Share -$0.21 -$0.27
Diluted Earnings Per Share -$0.21 -$0.27
COMMON SHARES
Basic Shares Outstanding 49.50M 49.39M
Diluted Shares Outstanding 49.50M 49.42M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.90M $45.22M
YoY Change -54.33% -51.54%
Cash & Equivalents $12.56M $8.923M
Short-Term Investments $23.34M $36.30M
Other Short-Term Assets $2.967M $2.938M
YoY Change -15.35% -23.59%
Inventory $25.21M $24.80M
Prepaid Expenses
Receivables $12.79M $16.55M
Other Receivables $0.00 $0.00
Total Short-Term Assets $76.86M $89.51M
YoY Change -34.28% -29.05%
LONG-TERM ASSETS
Property, Plant & Equipment $7.546M $8.164M
YoY Change -30.41% -26.71%
Goodwill $18.26M $18.26M
YoY Change 0.0% 0.0%
Intangibles $15.27M $15.99M
YoY Change -15.73% -16.41%
Long-Term Investments $3.399M $3.496M
YoY Change
Other Assets $731.0K $647.0K
YoY Change 11.77% -6.91%
Total Long-Term Assets $53.11M $54.23M
YoY Change -11.91% -13.52%
TOTAL ASSETS
Total Short-Term Assets $76.86M $89.51M
Total Long-Term Assets $53.11M $54.23M
Total Assets $130.0M $143.7M
YoY Change -26.67% -23.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.760M $9.785M
YoY Change -26.32% -16.6%
Accrued Expenses $9.368M $13.17M
YoY Change -29.0% -10.58%
Deferred Revenue $6.188M $6.461M
YoY Change -9.66% -10.44%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.026M $642.0K
YoY Change 28.25% -21.9%
Total Short-Term Liabilities $27.99M $32.74M
YoY Change -21.2% -12.44%
LONG-TERM LIABILITIES
Long-Term Debt $75.90M $75.68M
YoY Change 18.94% 18.93%
Other Long-Term Liabilities $40.00K $40.00K
YoY Change -71.43% -99.73%
Total Long-Term Liabilities $75.94M $75.72M
YoY Change 18.74% 19.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.99M $32.74M
Total Long-Term Liabilities $75.94M $75.72M
Total Liabilities $116.3M $121.5M
YoY Change 0.93% 3.86%
SHAREHOLDERS EQUITY
Retained Earnings -$277.2M -$266.7M
YoY Change 26.44% 29.25%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.63M $22.25M
YoY Change
Total Liabilities & Shareholders Equity $130.0M $143.7M
YoY Change -26.67% -23.9%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$10.53M -$13.15M
YoY Change -18.45% -36.79%
Depreciation, Depletion And Amortization $1.825M $1.926M
YoY Change -28.99% 4.28%
Cash From Operating Activities -$9.256M -$11.04M
YoY Change -32.73% -6.46%
INVESTING ACTIVITIES
Capital Expenditures $434.0K $170.0K
YoY Change -47.71% -88.05%
Acquisitions
YoY Change
Other Investing Activities $13.45M $9.224M
YoY Change
Cash From Investing Activities $13.02M $9.054M
YoY Change -1668.55% -736.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -150.0K -2.125M
YoY Change 7.14% -104.59%
NET CHANGE
Cash From Operating Activities -9.256M -11.04M
Cash From Investing Activities 13.02M 9.054M
Cash From Financing Activities -150.0K -2.125M
Net Change In Cash 3.613M -4.112M
YoY Change -124.53% -112.42%
FREE CASH FLOW
Cash From Operating Activities -$9.256M -$11.04M
Capital Expenditures $434.0K $170.0K
Free Cash Flow -$9.690M -$11.21M
YoY Change -33.58% -15.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OperatingExpenses
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49419982
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40639714
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49304076
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39489261
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OperatingExpenses
akya Standard Service Based Warranty Terms
StandardServiceBasedWarrantyTerms
P1Y
akya Extended Service Based Warranty Terms
ExtendedServiceBasedWarrantyTerms
P1Y
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49467363
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49117738
dei Entity Central Index Key
EntityCentralIndexKey
0001711933
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49467363
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49117738
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40344
dei Entity Registrant Name
EntityRegistrantName
Akoya Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5586242
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Campus Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
896-8401
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AKYA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49499487
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8923000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83125000
CY2024Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
36301000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16554000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16994000
CY2024Q2 us-gaap Inventory Net
InventoryNet
24796000
CY2023Q4 us-gaap Inventory Net
InventoryNet
17877000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2938000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3794000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
89512000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
121790000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8164000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10729000
CY2024Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3496000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
704000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
699000
CY2024Q2 akya Demo Inventory Net
DemoInventoryNet
666000
CY2023Q4 akya Demo Inventory Net
DemoInventoryNet
893000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15986000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17412000
CY2024Q2 us-gaap Goodwill
Goodwill
18262000
CY2023Q4 us-gaap Goodwill
Goodwill
18262000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5154000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8365000
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1154000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1562000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
647000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
657000
CY2024Q2 us-gaap Assets
Assets
143745000
CY2023Q4 us-gaap Assets
Assets
180369000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9785000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11776000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13170000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13433000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2680000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2681000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
642000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
767000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6461000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6688000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
32738000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35345000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3170000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3193000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
75684000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
75254000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
75000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5155000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6238000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
537000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
766000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4097000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5765000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000
CY2024Q2 us-gaap Liabilities
Liabilities
121496000
CY2023Q4 us-gaap Liabilities
Liabilities
126599000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49467363
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49117738
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
288963000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
283839000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266704000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-230071000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
22249000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
53770000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143745000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180369000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23164000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41514000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44931000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
9778000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
11405000
us-gaap Cost Of Revenue
CostOfRevenue
19749000
us-gaap Cost Of Revenue
CostOfRevenue
20522000
CY2024Q2 us-gaap Gross Profit
GrossProfit
13386000
CY2023Q2 us-gaap Gross Profit
GrossProfit
12116000
us-gaap Gross Profit
GrossProfit
21765000
us-gaap Gross Profit
GrossProfit
24409000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19094000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23905000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38957000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47030000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5288000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6923000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10842000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13300000
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
88000
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
530000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
267000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
757000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1397000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
24470000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
31358000
us-gaap Operating Expenses
OperatingExpenses
54434000
us-gaap Operating Expenses
OperatingExpenses
61087000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11084000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19242000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32669000
us-gaap Operating Income Loss
OperatingIncomeLoss
-36678000
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2606000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2175000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5218000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4229000
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
668000
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
737000
us-gaap Interest And Other Income
InterestAndOtherIncome
1605000
us-gaap Interest And Other Income
InterestAndOtherIncome
1502000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-105000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-241000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-153000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13102000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20785000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36523000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39558000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
110000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13149000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
us-gaap Net Income Loss
NetIncomeLoss
-36633000
us-gaap Net Income Loss
NetIncomeLoss
-39605000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49419982
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40639714
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49304076
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39489261
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13149000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
us-gaap Net Income Loss
NetIncomeLoss
-36633000
us-gaap Net Income Loss
NetIncomeLoss
-39605000
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13145000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20803000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36645000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39599000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
53770000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36000
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
149000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-23484000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2566000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
32723000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2024Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
65000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13149000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2713000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
22249000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58581000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
94000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18802000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2375000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
42124000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
143000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47817000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2620000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71901000
us-gaap Profit Loss
ProfitLoss
-36633000
us-gaap Profit Loss
ProfitLoss
-39605000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3977000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4208000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
430000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
359000
us-gaap Share Based Compensation
ShareBasedCompensation
5279000
us-gaap Share Based Compensation
ShareBasedCompensation
4995000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
37000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
267000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
757000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
915000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
1026000
us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
5000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
1142000
akya Operating Lease Adjustment
OperatingLeaseAdjustment
1156000
akya Change In Inventory Reserve Adjustment
ChangeInInventoryReserveAdjustment
2779000
akya Change In Inventory Reserve Adjustment
ChangeInInventoryReserveAdjustment
2198000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
475000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3137000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-866000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2342000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9597000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4045000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1991000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1104000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
528000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2140000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1084000
akya Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1065000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-250000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1316000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31865000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31562000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
980000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2227000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
69783000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5000000
akya Maturities Of Marketable Securities
MaturitiesOfMarketableSecurities
26000000
akya Maturities Of Marketable Securities
MaturitiesOfMarketableSecurities
7000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39763000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4773000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48071000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
201000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
214000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
94000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
354000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
321000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33000
akya Refunds From Payments Of Deferred Offering Costs
RefundsFromPaymentsOfDeferredOfferingCosts
-150000
akya Refunds From Payments Of Deferred Offering Costs
RefundsFromPaymentsOfDeferredOfferingCosts
-207000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1910000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1709000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2569000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45908000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-74197000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19119000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74532000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9627000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93651000
us-gaap Interest Paid Net
InterestPaidNet
4588000
us-gaap Interest Paid Net
InterestPaidNet
3705000
akya Right Of Use Asset Obtained In Exchange For Lease Liabilities
RightOfUseAssetObtainedInExchangeForLeaseLiabilities
914000
akya Unpaid Stock Offering Costs
UnpaidStockOfferingCosts
254000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
44000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
596000
akya Number Of Geographic Regions For Sales
NumberOfGeographicRegionsForSales
3
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
48720000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266704000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31865000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23164000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41514000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44931000
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2248000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1276000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
960000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Cost Basis Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesCostBasisDueOneToTwoYears
3498000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLossesDueOneToTwoYears
2000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure Due One To Two Years
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosureDueOneToTwoYears
3496000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
46349000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses
CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses
12000
CY2024Q2 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
46337000
CY2023Q4 akya Cash Cash Equivalents And Marketable Securities Cost Basis
CashCashEquivalentsAndMarketableSecuritiesCostBasis
76844000
CY2023Q4 akya Cash Cash Equivalents And Marketable Securities Fair Value Disclosure
CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
76844000
akya Number Of Debt Securities Held
NumberOfDebtSecuritiesHeld
6
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17969000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20392000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9805000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9663000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8164000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10729000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
902000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2024Q2 akya Demo Inventory Estimated Useful Life
DemoInventoryEstimatedUsefulLife
P3Y
CY2024Q2 akya Demo Inventory Gross
DemoInventoryGross
4272000
CY2023Q4 akya Demo Inventory Gross
DemoInventoryGross
4284000
CY2024Q2 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
3606000
CY2023Q4 akya Accumulated Depreciation Depletion And Amortization Demo Inventory
AccumulatedDepreciationDepletionAndAmortizationDemoInventory
3391000
CY2024Q2 akya Demo Inventory Net
DemoInventoryNet
666000
CY2023Q4 akya Demo Inventory Net
DemoInventoryNet
893000
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
16554000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
960000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
915000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
960000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29990000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14004000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15986000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29990000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12578000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17412000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1426000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1492000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1427000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2853000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2823000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1956000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1761000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5166000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15986000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4862000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7074000
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1935000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1911000
CY2024Q2 akya Accrued Inventory Purchases
AccruedInventoryPurchases
2317000
CY2023Q4 akya Accrued Inventory Purchases
AccruedInventoryPurchases
609000
CY2024Q2 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
786000
CY2023Q4 akya Customer Deposit Liability Current
CustomerDepositLiabilityCurrent
1096000
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
765000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
711000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2505000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2032000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13170000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13433000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
390000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
448000
CY2024Q2 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
1074000
CY2023Q4 akya Debt Instrument Accretion Of Fee
DebtInstrumentAccretionOfFee
702000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
75684000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
75254000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2024Q2 akya Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49467363
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49117738
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11030552
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8924291
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
110000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13149000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-20803000
us-gaap Net Income Loss
NetIncomeLoss
-36633000
us-gaap Net Income Loss
NetIncomeLoss
-39605000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49419982
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40639714
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49304076
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39489261
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8307418
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7562888
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23164000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23521000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41514000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44931000
akya Number Of Countries With Concentration Risk
NumberOfCountriesWithConcentrationRisk
0
akya Number Of Countries With Concentration Risk
NumberOfCountriesWithConcentrationRisk
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2971000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
31000
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
44000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
65000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
64000
CY2024Q2 us-gaap Lease Cost
LeaseCost
788000
CY2023Q2 us-gaap Lease Cost
LeaseCost
1069000
us-gaap Lease Cost
LeaseCost
1770000
us-gaap Lease Cost
LeaseCost
2102000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1452000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2835000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2636000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1104000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
436000
CY2024Q2 akya Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
562000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9025000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1190000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7835000
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
378000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
444000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
239000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
239000
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
60000
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1360000
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
181000
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1179000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0785
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1017
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0911
us-gaap Operating Lease Payments
OperatingLeasePayments
1398000
us-gaap Operating Lease Payments
OperatingLeasePayments
1533000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
65000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
64000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
354000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
321000
us-gaap Restructuring Charges
RestructuringCharges
1257000
akya Employee And Equipment Relocation Costs
EmployeeAndEquipmentRelocationCosts
140000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
akya-20240630_cal.xml Edgar Link unprocessable
0001558370-24-010883-index-headers.html Edgar Link pending
0001558370-24-010883-index.html Edgar Link pending
0001558370-24-010883.txt Edgar Link pending
0001558370-24-010883-xbrl.zip Edgar Link pending
akya-20240630.xsd Edgar Link pending
akya-20240630x10q.htm Edgar Link pending
akya-20240630xex10d1.htm Edgar Link pending
akya-20240630xex31d1.htm Edgar Link pending
akya-20240630xex31d2.htm Edgar Link pending
akya-20240630xex32d1.htm Edgar Link pending
akya-20240630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
akya-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
akya-20240630_lab.xml Edgar Link unprocessable
akya-20240630x10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
akya-20240630_pre.xml Edgar Link unprocessable